Purchase Order W81K0021P0021
Award Date 11/13/20
Potential Completion Date 12/11/20
Potential Value $97K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Indianapolis, IN 46250, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
- This $90,000.00 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for MAGNA PURE 96 products. The contract has no set-aside designation and has a completion date of July 23, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have previously received prime contract and subcontract awards from various federal...
- The Department of the Army Medical Command awarded a firm-fixed-price purchase order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, to provide a MAGNA PURE 96 INSTRUMENT IVD. The contract has a potential value of $194,000.00 and a completion date of January 11, 2021. This award was made through a special notice solicitation using simplified acquisition procedures and was not set aside for any...
- This federal contract award is for the MAGNA PURE 96 SYSTEM, a purchase order valued at $97,000.00 awarded to the prime contractor Roche Diagnostics Corporation by the U.S. Army Medical Command (MEDCOM). The contract has a completion date of September 22, 2021 and was awarded on September 14, 2021. This purchase order was not set aside for any specific business category. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 INSTRUMENT IVD, with a ceiling value of $90,000.00 and a completion date of July 15, 2017. Roche Diagnostics has received numerous federal contract awards, including through its...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $947,520.62, was awarded by the Medical Command within the U.S. Department of Defense on October 1, 2020 for a period ending on September 30, 2021. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation....
- This is a $109,000.00 firm fixed price purchase order awarded by the Air Education and Training Command, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation for the MAGNA PURE 96 INSTRUMENT. The award did not utilize a set-aside program. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, and has received numerous federal contract awards to supply medical equipment and...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for ROCHE MAGNA PURE 96 laboratory equipment. The contract has a ceiling value of $90,000.00 and a completion date of September 29, 2022. Roche Diagnostics has experience as a prime contractor and subcontractor providing medical equipment, reagents, and associated products and services to various federal agencies, including the Department of Veterans Affairs,...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the MAGNA PURE96 INSTRUMENT. The contract has a ceiling value of $91,563.00 and an ultimate completion date of August 31, 2017. The contract is not designated as a set-aside. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the acquisition of MAGNA PURE EQUIPMENT and does not have a set-aside designation. Roche Diagnostics has received multiple prime contract and subcontract awards from various federal agencies to provide...